ProKidney is trading at $1.89, down -5.28%, on September 9, 2026, amid softer U.S. markets, rising oil prices, geopolitical tensions, and renewed interest-rate concerns.
- No fresh company-specific announcement was identified.
- The latest reported update was ProKidney’s August 10, 2026, quarterly release and PROACT 1 enrollment progress.
- The move appears primarily global rather than company-driven.